Bipartisan Congress Intensifies Efforts to Restrict Orphan Drug Exclusivity

Published date19 March 2020
Subject MatterFDA,Orphan Drugs,Pharmaceutical Industry
AuthorSarah Cork Ph.D.
Law FirmProskauer - Minding Your Business

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT